These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4899241)

  • 21. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia.
    Thomas DR
    Clin Nutr; 2007 Aug; 26(4):389-99. PubMed ID: 17499396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The possible role of myostatin in skeletal muscle atrophy and cachexia.
    Jespersen J; Kjaer M; Schjerling P
    Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mitochondrial abnormalities and ocular myopathies with downward-spreading evolution. Apropos of 2 new cases].
    Herlicoviez D
    Pathol Biol (Paris); 1975 Feb; 23(2):107-17. PubMed ID: 124043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Postoperative prognosis and treatment of valvular heart disease with cardiac cachexia from the view point of total pulmonary vascular resistance].
    Okamura K; Atsumi N; Watanabe Y; Sakai A; Maeta H; Mitsui T; Hori M
    Kyobu Geka; 1987 May; 40(6):441-9. PubMed ID: 3613316
    [No Abstract]   [Full Text] [Related]  

  • 25. Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?
    Penna F; Bonetto A; Muscaritoli M; Costamagna D; Minero VG; Bonelli G; Rossi Fanelli F; Baccino FM; Costelli P
    Int J Cancer; 2010 Oct; 127(7):1706-17. PubMed ID: 20039316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular mechanisms promoting cachexia and how they are opposed by sirtuins
    Samant SA; Pillai VB; Gupta MP
    Can J Physiol Pharmacol; 2019 Apr; 97(4):235-245. PubMed ID: 30407871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel in vitro platform to investigate myotube atrophy.
    Oelkrug C; Horn K; Makert GR; Schubert A
    Anticancer Res; 2015 Apr; 35(4):2085-91. PubMed ID: 25862864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The extrapyramidal disorder of Alzheimer's disease.
    Pearce J
    Eur Neurol; 1974; 12(2):94-103. PubMed ID: 4426320
    [No Abstract]   [Full Text] [Related]  

  • 30. Powerful signals for weak muscles.
    Saini A; Faulkner S; Al-Shanti N; Stewart C
    Ageing Res Rev; 2009 Oct; 8(4):251-67. PubMed ID: 19716529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
    Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
    Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on emerging drugs for cancer cachexia.
    Murphy KT; Lynch GS
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):619-32. PubMed ID: 19860537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.
    Argilés JM; Anguera A; Stemmler B
    Clin Nutr; 2013 Jun; 32(3):319-24. PubMed ID: 23395103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men.
    Lexell J; Taylor CC; Sjöström M
    J Neurol Sci; 1988 Apr; 84(2-3):275-94. PubMed ID: 3379447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Last Word on Viewpoint: Muscle atrophy is not always sarcopenia.
    Hepple RT
    J Appl Physiol (1985); 2012 Aug; 113(4):685. PubMed ID: 22896681
    [No Abstract]   [Full Text] [Related]  

  • 36. The muscular atrophy of central origin (an ultramicroscopic study on muscle biopsy material).
    Botez MI; Petrovici A; Constantinescu S; Popescu F
    Rev Roum Neurol; 1970; 7(3):217-9. PubMed ID: 4366178
    [No Abstract]   [Full Text] [Related]  

  • 37. A non-human primate model of radiation-induced cachexia.
    Cui W; Bennett AW; Zhang P; Barrow KR; Kearney SR; Hankey KG; Taylor-Howell C; Gibbs AM; Smith CP; MacVittie TJ
    Sci Rep; 2016 Mar; 6():23612. PubMed ID: 27029502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia.
    Acharyya S; Butchbach ME; Sahenk Z; Wang H; Saji M; Carathers M; Ringel MD; Skipworth RJ; Fearon KC; Hollingsworth MA; Muscarella P; Burghes AH; Rafael-Fortney JA; Guttridge DC
    Cancer Cell; 2005 Nov; 8(5):421-32. PubMed ID: 16286249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerobic exercise training as therapy for cardiac and cancer cachexia.
    Alves CR; da Cunha TF; da Paixão NA; Brum PC
    Life Sci; 2015 Mar; 125():9-14. PubMed ID: 25500304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.